Viktor Drvota M.D, Ph.D
Viktor Drvota is Deputy Chief Executive Officer and Chief Investment Officer at Karolinska Development. He has more than 13 years of Venture Capital experience with several investments, significant fundraisings, IPOs and exits. He was responsible for Life science at SEB Venture Capital 2002 -2016. During his appointment at SEB VC he also served as a Board member in several biotech and Medtech companies such as Arexis AB, SBL Vaccin AB, Nuevolution AS, Index Pharma AB, Scibase AB, Airsonett AB among others. Before joining SEB in, Dr Drvota worked as Senior Consultant and Associate Professor in Cardiology at the Karolinska Institutet/hospital, Stockholm. He has experience from preclinical as well as clinical research in drug development and medical devices. Dr Drvota has 29 published research articles.